Ketamine Assisted Psychotherapy for Opioid Use Disorder

Part of paid clinical trials in Salt Lake City, Utah.

Sponsor
University of Utah
Study ID
NCT04892251
Phase
PHASE1/PHASE2
Status
Recruiting
Apply to this trial

Conditions

  • Opioid-use Disorder

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • MORE+KAP — COMBINATION_PRODUCT
    Mindfulness-Oriented Recovery Enhancement plus two sessions where 0.5 to 1.5 mg/kg of ketamine are administered intramuscularly
  • MORE — BEHAVIORAL
    Mindfulness-Oriented Recovery Enhancement

Study Details

This pilot clinical trial aims to assess the preliminary efficacy of ketamine as an adjunct for a mindfulness-based intervention for opioid use disorder.

Key Dates

Start date
May 20, 2021
Status verified
Jul 2023
Primary completion
Dec 30, 2023
Completion
May 30, 2024

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: MORE+KAP
    8 weeks of Mindfulness-Oriented Recovery Enhancement plus two ketamine assisted psychotherapy sessions
  • Active Comparator: MORE
    8 weeks of Mindfulness-Oriented Recovery Enhancement

Primary Outcome Measure

Drug use [ Time Frame: From baseline to 3-month follow-up ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Center on Mindfulness and Integrative Health Intervention DevelopmentSalt Lake CityUtah84112
Research Coordinator
[email protected]

Find similar trials in Salt Lake City, UT

By research site
Center on Mindfulness and Integrative Health Intervention Development· Salt Lake City, UT

Related Studies